{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:21:34Z","timestamp":1793650894577,"version":"4.5.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2017R1D1A1B03028155."],"award-info":[{"award-number":["NRF-2017R1D1A1B03028155."]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Technology Innovation Program (Industrial Strategic Technology Development Program","award":["MOTIE-20003838"],"award-info":[{"award-number":["MOTIE-20003838"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Clinical use of mesenchymal stem cells (MSCs) requires a uniform cell population, and their harvesting is invasive and produces a limited number of cells. Human embryonic stem cell-derived MSCs (hESC-MSCs) can differentiate into three germ layers and possess immunosuppressive effects in vitro. Anticancer treatment is a well-known risk factor for premature ovarian failure (POF). In this study, we investigated the effect of hESC-MSC on recovery of ovarian function in cisplatin-induced POF in mice.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Female mice received intraperitoneal cisplatin for 10\u2009days. On day 12, CHA15-derived hESC-MSCs were transplanted into the mice by tail vein injection. An injection of PBS served as the negative control. Ovaries were removed 28\u2009days after transplantation for assessment of ovarian histology, immunostaining, and fertility testing by superovulation and in vitro fertilization. hESC-MSC transplantation into mice with cisplatin-induced damage restored body weight and ovary size.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Mean primary and primordial follicle counts in the hESC-MSC group were significantly improved compared to the PBS group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), and counts of zona pellucida remnants, an apoptotic sign in ovarian follicles, were significantly reduced (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). TUNEL assays and cleaved PARP immunostaining indicated apoptosis, which led to loss of ovarian stromal cells in negative control mice, while Ki-67 was higher in the hESC-MSC group and in non-cisplatin-treated controls than in the PBS group. Ovulation was reduced in the PBS group but recovered significantly in the hESC-MSC group. Rates of blastocyst formation from ovulated eggs and live births per mouse also recovered significantly in the hESC-MSC group.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>hESC-MSC restored structure and function in the cisplatin-damaged ovary. Our study provides new insights into the great clinical potential of human hESC-MSC in treating POF.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13287-020-01769-6","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T04:37:20Z","timestamp":1593146240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice"],"prefix":"10.1186","volume":"11","author":[{"given":"Sook Young","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ah","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sookyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeoung Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hee","family":"Eum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haengseok","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ryul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Woo","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"issue":"5","key":"1769_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ejca.2003.11.026","volume":"40","author":"FY de Vos","year":"2004","unstructured":"de Vos FY, Nuver J, Willemse PH, van der Zee AG, Messerschmidt J, Burgerhof JG, et al. Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damage. Eur J Cancer. 2004;40(5):696\u2013700.","journal-title":"Eur J Cancer."},{"issue":"10","key":"1769_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3109\/09513590.2010.487599","volume":"26","author":"MB Lana","year":"2010","unstructured":"Lana MB, Straminsky V, Onetto C, Amuchastegui JM, Blanco G, Galluzzo L, et al. What is really responsible for bone loss in spontaneous premature ovarian failure? A new enigma. Gynecol Endocrinol. 2010;26(10):755\u20139.","journal-title":"Gynecol Endocrinol."},{"issue":"1","key":"1769_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/jfprhc.2010.0015","volume":"37","author":"K Maclaran","year":"2011","unstructured":"Maclaran K, Panay N. Premature ovarian failure. J Fam Plann Reprod Health Care. 2011;37(1):35\u201342.","journal-title":"J Fam Plann Reprod Health Care."},{"issue":"11","key":"1769_CR4","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1200\/JCO.2004.08.094","volume":"22","author":"IF Tannock","year":"2004","unstructured":"Tannock IF, Ahles TA, Ganz PA, Van Dam FS. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004;22(11):2233\u20139.","journal-title":"J Clin Oncol."},{"issue":"12","key":"1769_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s12094-016-1587-9","volume":"18","author":"M Munoz","year":"2016","unstructured":"Munoz M, Santaballa A, Segui MA, Beato C, de la Cruz S, Espinosa J, et al. SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016). Clin Transl Oncol. 2016;18(12):1229\u201336.","journal-title":"Clin Transl Oncol."},{"issue":"1","key":"1769_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","volume":"7","author":"JL Spees","year":"2016","unstructured":"Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem\/stromal cell function. Stem Cell Res Ther. 2016;7(1):125.","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"1769_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12015-017-9765-x","volume":"14","author":"Z Fazeli","year":"2018","unstructured":"Fazeli Z, Abedindo A, Omrani MD, Ghaderian SMH. Mesenchymal stem cells (MSCs) therapy for recovery of fertility: a systematic review. Stem Cell Rev. 2018;14(1):1\u201312.","journal-title":"Stem Cell Rev."},{"issue":"4","key":"1769_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2217\/rme.14.13","volume":"9","author":"R Gadkari","year":"2014","unstructured":"Gadkari R, Zhao L, Teklemariam T, Hantash BM. Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy. Regen Med. 2014;9(4):453\u201365.","journal-title":"Regen Med."},{"key":"1769_CR9","doi-asserted-by":"publisher","unstructured":"Jun SM, Park M, Lee JY, Jung S, Lee JE, Shim SH, et al. Single cell-derived clonally expanded mesenchymal progenitor cells from somatic cell nuclear transfer-derived pluripotent stem cells ameliorate the endometrial function in the uterus of a murine model with Asherman\u2019s syndrome. Cell Prolif. 2019:e12597. https:\/\/doi.org\/10.1111\/cpr.12597.","DOI":"10.1111\/cpr.12597"},{"issue":"12","key":"1769_CR10","doi-asserted-by":"publisher","first-page":"e0144245","DOI":"10.1371\/journal.pone.0144245","volume":"10","author":"EM Chang","year":"2015","unstructured":"Chang EM, Lim E, Yoon S, Jeong K, Bae S, Lee DR, et al. Cisplatin induces overactivation of the dormant primordial follicle through PTEN\/AKT\/FOXO3a pathway which leads to loss of ovarian reserve in mice. PLoS One. 2015;10(12):e0144245.","journal-title":"PLoS One."},{"issue":"5","key":"1769_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1530\/rep.1.00095","volume":"127","author":"M Myers","year":"2004","unstructured":"Myers M, Britt KL, Wreford NG, Ebling FJ, Kerr JB. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004;127(5):569\u201380.","journal-title":"Reproduction."},{"issue":"1","key":"1769_CR12","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers3011351","volume":"3","author":"AM Florea","year":"2011","unstructured":"Florea AM, Busselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel). 2011;3(1):1351\u201371.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"1769_CR13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/0002-9378(92)91335-8","volume":"166","author":"J Byrne","year":"1992","unstructured":"Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166(3):788\u201393.","journal-title":"Am J Obstet Gynecol."},{"issue":"6","key":"1769_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/humupd\/7.6.535","volume":"7","author":"D Meirow","year":"2001","unstructured":"Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7(6):535\u201343.","journal-title":"Hum Reprod Update."},{"issue":"2","key":"1769_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12272-012-0202-z","volume":"35","author":"T Yi","year":"2012","unstructured":"Yi T, Song SU. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch Pharm Res. 2012;35(2):213\u201321.","journal-title":"Arch Pharm Res."},{"issue":"8","key":"1769_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00277-012-1438-x","volume":"91","author":"M Zaim","year":"2012","unstructured":"Zaim M, Karaman S, Cetin G, Isik S. Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells. Ann Hematol. 2012;91(8):1175\u201386.","journal-title":"Ann Hematol."},{"key":"1769_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2121-9-60","volume":"9","author":"JD Kretlow","year":"2008","unstructured":"Kretlow JD, Jin YQ, Liu W, Zhang WJ, Hong TH, Zhou G, et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol. 2008;9:60.","journal-title":"BMC Cell Biol."},{"issue":"6","key":"1769_CR18","doi-asserted-by":"publisher","first-page":"e5846","DOI":"10.1371\/journal.pone.0005846","volume":"4","author":"W Wagner","year":"2009","unstructured":"Wagner W, Bork S, Horn P, Krunic D, Walenda T, Diehlmann A, et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One. 2009;4(6):e5846.","journal-title":"PLoS One."},{"key":"1769_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1742-4933-5-5","volume":"5","author":"A Kriete","year":"2008","unstructured":"Kriete A, Mayo KL, Yalamanchili N, Beggs W, Bender P, Kari C, et al. Cell autonomous expression of inflammatory genes in biologically aged fibroblasts associated with elevated NF-kappaB activity. Immun Aging. 2008;5:5.","journal-title":"Immun Aging."},{"issue":"7","key":"1769_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/bioinformatics\/btp073","volume":"25","author":"JP de Magalhaes","year":"2009","unstructured":"de Magalhaes JP, Curado J, Church GM. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009;25(7):875\u201381.","journal-title":"Bioinformatics."},{"issue":"Suppl 1","key":"1769_CR21","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4\u20139.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"7","key":"1769_CR22","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/stem.1111","volume":"30","author":"G Moll","year":"2012","unstructured":"Moll G, Rasmusson-Duprez I, von Bahr L, Connolly-Andersen AM, Elgue G, Funke L, et al. Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells. 2012;30(7):1565\u201374.","journal-title":"Stem Cells."},{"issue":"12","key":"1769_CR23","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.biochi.2013.07.015","volume":"95","author":"SH Kupcova","year":"2013","unstructured":"Kupcova SH. Proteomic techniques for characterization of mesenchymal stem cell secretome. Biochimie. 2013;95(12):2196\u2013211.","journal-title":"Biochimie."},{"issue":"1","key":"1769_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jcyt.2012.08.001","volume":"15","author":"SH Abd-Allah","year":"2013","unstructured":"Abd-Allah SH, Shalaby SM, Pasha HF, El-Shal AS, Raafat N, Shabrawy SM, et al. Mechanistic action of mesenchymal stem cell injection in the treatment of chemically induced ovarian failure in rabbits. Cytotherapy. 2013;15(1):64\u201375.","journal-title":"Cytotherapy."},{"issue":"4","key":"1769_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/14653240802035926","volume":"10","author":"X Fu","year":"2008","unstructured":"Fu X, He Y, Xie C, Liu W. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy. 2008;10(4):353\u201363.","journal-title":"Cytotherapy."},{"issue":"5","key":"1769_CR26","first-page":"2527","volume":"41","author":"G Liu","year":"2018","unstructured":"Liu G, Lv H, An Y, Wei X, Yi X, Yi H. Tracking of transplanted human umbilical cord-derived mesenchymal stem cells labeled with fluorescent probe in a mouse model of acute lung injury. Int J Mol Med. 2018;41(5):2527\u201334.","journal-title":"Int J Mol Med."},{"issue":"1","key":"1769_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/ijms.21666","volume":"15","author":"V Volarevic","year":"2018","unstructured":"Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, et al. Ethical and safety issues of stem cell-based therapy. Int J Med Sci. 2018;15(1):36\u201345.","journal-title":"Int J Med Sci."},{"key":"1769_CR28","doi-asserted-by":"crossref","first-page":"518135","DOI":"10.1155\/2014\/518135","volume":"2014","author":"C de Rham","year":"2014","unstructured":"de Rham C, Villard J. Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy. J Immunol Res. 2014;2014:518135.","journal-title":"J Immunol Res."},{"issue":"1","key":"1769_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5653\/cerm.2019.46.1.1","volume":"46","author":"SY Yoon","year":"2019","unstructured":"Yoon SY. Mesenchymal stem cells for restoration of ovarian function. Clin Exp Reprod Med. 2019;46(1):1\u20137.","journal-title":"Clin Exp Reprod Med."},{"key":"1769_CR30","doi-asserted-by":"crossref","unstructured":"Khader A, Arinzeh TL. Biodegradable zinc oxide composite scaffolds promote osteochondral differentiation of mesenchymal stem cells. Biotechnol Bioeng. 2019;117(1):194\u2013209.","DOI":"10.1002\/bit.27173"},{"issue":"1","key":"1769_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/sctm.18-0085","volume":"8","author":"C Menale","year":"2019","unstructured":"Menale C, Campodoni E, Palagano E, Mantero S, Erreni M, Inforzato A, et al. Mesenchymal stromal cell-seeded biomimetic scaffolds as a factory of soluble RANKL in Rankl-deficient osteopetrosis. Stem Cells Transl Med. 2019;8(1):22\u201334.","journal-title":"Stem Cells Transl Med."},{"issue":"1","key":"1769_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13287-018-0953-7","volume":"9","author":"B Huang","year":"2018","unstructured":"Huang B, Lu J, Ding C, Zou Q, Wang W, Li H. Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD. Stem Cell Res Ther. 2018;9(1):216.","journal-title":"Stem Cell Res Ther."},{"key":"1769_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fcvm.2017.00063","volume":"4","author":"GR Willis","year":"2017","unstructured":"Willis GR, Kourembanas S, Mitsialis SA. Toward exosome-based therapeutics: isolation, heterogeneity, and fit-for-purpose potency. Front Cardiovasc Med. 2017;4:63.","journal-title":"Front Cardiovasc Med."},{"issue":"1","key":"1769_CR34","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/s41598-017-02786-x","volume":"7","author":"L Sun","year":"2017","unstructured":"Sun L, Li D, Song K, Wei J, Yao S, Li Z, et al. Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro. Sci Rep. 2017;7(1):2552.","journal-title":"Sci Rep."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01769-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-01769-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01769-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:08:46Z","timestamp":1624666126000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01769-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1769"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01769-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"7 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of CHA University (IACUC 170138). Human blood for positive control of genomic DNA was donated with written consent under approval by the institutional review board (IRB) of CHA University (1044308-201803-BR-014-02).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}